GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ABL Bio Inc (XKRX:298380) » Definitions » Other Current Receivables

ABL Bio (XKRX:298380) Other Current Receivables : ₩213 Mil (As of Jun. 2024)


View and export this data going back to 2018. Start your Free Trial

What is ABL Bio Other Current Receivables?

ABL Bio's Other Current Receivables for the quarter that ended in Jun. 2024 was ₩213 Mil.

ABL Bio's quarterly Other Current Receivables declined from Dec. 2023 (₩260.89 Mil) to Mar. 2024 (₩247.79 Mil) but then stayed the same from Mar. 2024 (₩247.79 Mil) to Jun. 2024 (₩213.37 Mil).

ABL Bio's annual Other Current Receivables increased from Dec. 2021 (₩83.87 Mil) to Dec. 2022 (₩451.78 Mil) but then declined from Dec. 2022 (₩451.78 Mil) to Dec. 2023 (₩260.89 Mil).


ABL Bio Other Current Receivables Historical Data

The historical data trend for ABL Bio's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ABL Bio Other Current Receivables Chart

ABL Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Receivables
Get a 7-Day Free Trial 442.18 759.02 83.87 451.78 260.89

ABL Bio Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 295.24 325.04 260.89 247.79 213.37

ABL Bio Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


ABL Bio Other Current Receivables Related Terms

Thank you for viewing the detailed overview of ABL Bio's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


ABL Bio Business Description

Traded in Other Exchanges
N/A
Address
2nd Floor, 16 Daewangpangyo-Ro 712, Beon-Gil, Bundang-Gu, Gyeonggi-do, Seongnam-si, KOR, 13488
ABL Bio Inc is a Korean biotech research company. The company is engaged in the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline products include ABL001 an Bispecific Antibody, ABL201-205 an Antibody Drug Conjugate, T cell engager, Dual Immune Cell Targeting BsAb an Immuno-Oncology, ABL301 an BBB-Penetrating Bispecific Antibody.

ABL Bio Headlines

No Headlines